KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Short-term Investments (2016 - 2025)

Cvs Health (CVS) has disclosed Short-term Investments for 17 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments fell 10.88% year-over-year to $2.1 billion, compared with a TTM value of $2.1 billion through Dec 2025, down 10.88%, and an annual FY2025 reading of $2.1 billion, down 10.88% over the prior year.
  • Short-term Investments was $2.1 billion for Q4 2025 at Cvs Health, up from $2.1 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $3.8 billion in Q2 2024 and bottomed at $2.1 billion in Q3 2025.
  • Average Short-term Investments over 5 years is $2.9 billion, with a median of $3.0 billion recorded in 2021.
  • The sharpest move saw Short-term Investments grew 21.92% in 2024, then crashed 36.46% in 2025.
  • Year by year, Short-term Investments stood at $3.1 billion in 2021, then dropped by 10.88% to $2.8 billion in 2022, then grew by 17.31% to $3.3 billion in 2023, then decreased by 26.14% to $2.4 billion in 2024, then fell by 10.88% to $2.1 billion in 2025.
  • Business Quant data shows Short-term Investments for CVS at $2.1 billion in Q4 2025, $2.1 billion in Q3 2025, and $2.4 billion in Q2 2025.